Caroline Watts is a Research Fellow at the Sexual Health and Surveillance, Evaluation & Research Programs at the Kirby Institute. She holds a PhD in cancer epidemiology and health economics and an MPH. She is currently conducting cost-effectiveness analysis of using larvicides for malaria control in Kenya and point of care testing for sexually transmitted infections in remote communities in Australia. Previously she has conducted health economic evaluations of the management of people at high risk of melanoma. She holds a part-time appointment with the University of Sydney working across several melanoma related projects.
Phone
02 9385 0951
E-mail
cwatts@kirby.unsw.edu.au
Location
Kirby Institute, Level 6, Wallace Wurth Building, UNSW Sydney
Publications
Journal articles
Dempsey K; Ho G; Lo SN; McKeown J; Watts CG; Cust AE; Guitera P; Scolyer RA; Thompson JF; Morton RL; Menzies S; Madronio C; Mann G, 2025, 'Variation in initial biopsy technique for primary melanoma diagnosis: A population-based cohort study in New South Wales, Australia', JAAD International, 18, pp. 90 - 100, http://dx.doi.org/10.1016/j.jdin.2024.08.024
2025
Ni Y; Watts CG; Scolyer RA; Madronio C; Armstrong BK; Morton RL; Menzies SW; Mann GJ; Thompson JF; Cust AE; Lo SN, 2024, 'Prognosis for people with multiple primary melanomas compared with a single primary melanoma', Journal of the American Academy of Dermatology, 90, pp. 170 - 174, http://dx.doi.org/10.1016/j.jaad.2023.08.089
2024
Salam RA; Lo SN; Varey AHR; Spillane AJ; Henderson MA; Scolyer RA; Mar VJ; Thompson JF; Saw RPM; van Akkooi ACJ; Stretch JR; Button-Sloan A; Hong A; Morton RL; Watts CG; Smith AL; Cust AE, 2024, 'Impact of an online risk prediction tool for sentinel node metastasis on clinical decision-making in melanoma care: A mixed methods study', Surgical Oncology Insight, 1, pp. 100111 - 100111, http://dx.doi.org/10.1016/j.soi.2024.100111
2024
delos Trinos JPC; Coffeng LE; Garcia F; Belizario V; Wiseman V; Watts C; Vaz Nery S, 2024, 'Cost and budget impact of mass drug administration compared to expanded school-based targeted preventive chemotherapy for soil-transmitted helminth control in Zamboanga Peninsula, the Philippines', The Lancet Regional Health - Western Pacific, 50, http://dx.doi.org/10.1016/j.lanwpc.2024.101162
2024
Goldsbury D; McCarthy D; Watts C; So C; Wawryk O; Kearney C; Reyes-Marcelino G; McLoughlin K; Emery J; Cust A, 2024, 'Skin checks for potential skin cancers in general practice in Victoria, Australia: the upfront and downstream patterns and costs', Public Health Research & Practice, http://dx.doi.org/10.17061/phrp34122406
2024
Miao P; Terris-Prestholt F; Fairley CK; Tucker JD; Wiseman V; Mayaud P; Zhang Y; Rowley J; Gottlieb S; Korenromp EL; Watts CG; Ong JJ, 2024, 'Ignored and undervalued in public health: a systematic review of health state utility values associated with syphilis infection', Health and Quality of Life Outcomes, 22, http://dx.doi.org/10.1186/s12955-024-02234-1
2024
So C; Mccarthy D; Watts CG; Kearney C; Reyes-Marcelino G; Goldsbury DE; Mcloughlin K; Emery J; Cust AE, 2023, 'Diagnostic biopsies of suspected skin cancer in general practice from 2010 to 2017 in Victoria, Australia', British Journal of Dermatology, 188, pp. 560 - 561, http://dx.doi.org/10.1093/bjd/ljac111
2023
Reyes-Marcelino G; McLoughlin K; Harrison C; Watts CG; Kang YJ; Aranda S; Aitken JF; Guitera P; Cust AE, 2023, 'Skin cancer-related conditions managed in general practice in Australia, 2000-2016: A nationally representative, cross-sectional survey', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2022-067744
2023
Blake SC; Guitera P; Cust AE; Galea C; Lo SN; Scolyer RA; Armstrong BK; Thompson JF; Menzies SW; Madronio C; Morton RL; Mann GJ; Watts CG, 2023, 'The association of dermatologist demographic density with melanoma survival in New South Wales, Australia', Australasian Journal of Dermatology, 64, pp. 425 - 429, http://dx.doi.org/10.1111/ajd.14113
2023
Dunlop KLA; Keogh LA; Smith AL; Aranda S; Aitken J; Watts CG; Smit AK; Janda M; Mann GJ; Cust AE; Rankin NM, 2023, 'Acceptability and appropriateness of a risk-tailored organised melanoma screening program: Qualitative interviews with key informants', PLoS ONE, 18, http://dx.doi.org/10.1371/journal.pone.0287591
2023
Caesar delos Trinos JP; Ng-Nguyen D; Coffeng LE; Dyer CEF; Clarke N; Traub R; Halton K; Wiseman V; Watts C; Nery SV, 2023, 'Cost and cost-effectiveness analysis of mass drug administration compared to school-based targeted preventive chemotherapy for hookworm control in Dak Lak province, Vietnam', The Lancet Regional Health - Western Pacific, 41, http://dx.doi.org/10.1016/j.lanwpc.2023.100913
2023
Ni Y; Watts CG; Scolyer RA; Madronio C; Armstrong BK; Morton RL; Menzies SW; Mann GJ; Thompson JF; Lo SN; Cust AE, 2023, 'Risk of developing a second primary melanoma after a first primary melanoma in a population-based Australian cohort', British Journal of Dermatology, 188, pp. 814 - 816, http://dx.doi.org/10.1093/bjd/ljad076
2023
Causer L; Liu B; Watts C; McManus H; Donovan B; Ward J; Guy R, 2022, 'Hospitalisations for pelvic inflammatory disease in young Aboriginal women living in remote Australia: The role of chlamydia and gonorrhoea', Sexually Transmitted Infections, 98, pp. 445 - 447, http://dx.doi.org/10.1136/SEXTRANS-2021-055242
2022
Smith AL; Watts CG; Henderson M; Long GV; Rapport F; Saw RPM; Scolyer RA; Spillane AJ; Thompson JF; Cust AE, 2022, 'Factors influencing acceptance, adoption and adherence to sentinel node biopsy recommendations in the Australian Melanoma Management Guidelines: a qualitative study using an implementation science framework', Implementation Science Communications, 3, http://dx.doi.org/10.1186/s43058-022-00351-w
2022
Gordon LG; Shih S; Watts C; Goldsbury D; Green AC, 2022, 'The economics of skin cancer prevention with implications for Australia and New Zealand: where are we now?', Public Health Research and Practice, 32, http://dx.doi.org/10.17061/phrp31502119
2022
Barth DD; Cinanni G; Carapetis JR; Wyber R; Causer L; Watts C; Hengel B; Matthews S; Ralph AP; Pickering J; Cannon JW; Anderson L; Wade V; Guy RJ; Bowen AC, 2022, 'Roadmap to incorporating group A Streptococcus molecular point-of-care testing for remote Australia: a key activity to eliminate rheumatic heart disease', Medical Journal of Australia, 217, pp. 279 - 282, http://dx.doi.org/10.5694/mja2.51692
2022
Watts C; Spillane A; Henderson MA; Cust A; Braithwaite J; Gyorki DE; Hong AM; Kelly JW; Long GV; Mar VJ; Menzies AM; Morton RL; Rapport F; Saw RPM; Schmid H; Scolyer RA; Smith AL; Winder A; Mann GJ, 2022, 'Sentinel lymph node biopsy rates in Victoria, 2018 and 2019', Medical Journal of Australia, 217, pp. 208 - 209, http://dx.doi.org/10.5694/mja2.51424
2022
Watts C; Atieli H; Alacapa J; Lee M-C; Zhou G; Githeko A; Yan G; Wiseman V, 2021, 'Rethinking the Economic Costs of Hospitalisation for Malaria: Accounting for the Comorbidities of Malaria Patients in Western Kenya', , http://dx.doi.org/10.21203/rs.3.rs-561893/v1
2021
So C; Cust AE; Gordon LG; Morton RL; Canfell K; Ngo P; Dieng M; McLoughlin K; Watts C, 2021, 'Health utilities for non-melanoma skin cancers and pre-cancerous lesions: A systematic review', Skin Health and Disease, 1, http://dx.doi.org/10.1002/ski2.51
2021
Guitera P; Menzies SW; Coates E; Azzi A; Fernandez-Penas P; Lilleyman A; Badcock C; Schmid H; Watts CG; Collgros H; Liu R; Van Kemenade C; Mann GJ; Cust AE, 2021, 'Efficiency of Detecting New Primary Melanoma among Individuals Treated in a High-risk Clinic for Skin Surveillance', JAMA Dermatology, 157, pp. 521 - 530, http://dx.doi.org/10.1001/jamadermatol.2020.5651
2021
Watts C; Atieli H; Alacapa J; Lee MC; Zhou G; Githeko A; Yan G; Wiseman V, 2021, 'Rethinking the economic costs of hospitalization for malaria: accounting for the comorbidities of malaria patients in western Kenya', Malaria Journal, 20, http://dx.doi.org/10.1186/s12936-021-03958-x
2021
Watts CG; McLoughlin K; Goumas C; Van Kemenade CH; Aitken JF; Soyer HP; Fernandez Peñas P; Guitera P; Scolyer RA; Morton RL; Menzies SW; Caruana M; Kang YJ; Mann GJ; Chakera AH; Madronio CM; Armstrong BK; Thompson JF; Cust AE, 2021, 'Association between Melanoma Detected during Routine Skin Checks and Mortality', JAMA Dermatology, 157, pp. 1425 - 1436, http://dx.doi.org/10.1001/jamadermatol.2021.3884
2021
Hengel B; Causer L; Matthews S; Smith K; Andrewartha K; Badman S; Spaeth B; Tangey A; Cunningham P; Saha A; Phillips E; Ward J; Watts C; King J; Applegate T; Shephard M; Guy R, 2021, 'A decentralised point-of-care testing model to address inequities in the COVID-19 response', The Lancet Infectious Diseases, 21, pp. e183 - e190, http://dx.doi.org/10.1016/S1473-3099(20)30859-8
2021
Smith AL; Watts CG; Robinson S; Schmid H; Goumas C; Mar VJ; Thompson JF; Rapport F; Cust AE; Braithwaite J; Gyorki DE; Henderson M; Hong AM; Kelly JW; Long GV; Menzies AM; Morton RL; Saw RPM; Scolyer RA; Spillane AJ; Mann GJ, 2021, 'Knowledge and attitudes of Australian dermatologists towards sentinel lymph node biopsy for melanoma: a mixed methods study', Australasian Journal of Dermatology, 62, pp. 168 - 176, http://dx.doi.org/10.1111/ajd.13518
2021
Tran AD; Fogarty G; Nowak AK; Diaby V; Hong A; Watts C; Morton RL, 2020, 'Cost-Effectiveness of Subsequent Whole-Brain Radiotherapy or Hippocampal-Avoidant Whole-Brain Radiotherapy Versus Stereotactic Radiosurgery or Surgery Alone for Treatment of Melanoma Brain Metastases', Applied Health Economics and Health Policy, 18, pp. 679 - 687, http://dx.doi.org/10.1007/s40258-020-00560-1
2020
Watts CG; Smith AL; Robinson S; Chang CH; Goumas C; Schmid H; Kelly JW; Hong AM; Scolyer RA; Long GV; Spillane AJ; Henderson M; Gyorki DE; Mar VJ; Morton RL; Saw RPM; Varey AH; Mann GJ; Thompson JF; Cust AE, 2020, 'Australian general practitioners’ attitudes and knowledge of sentinel lymph node biopsy in melanoma management', Australian Journal of General Practice, 49, pp. 355 - 362, http://dx.doi.org/10.31128/AJGP-10-19-5138
2020
Rapport F; Smith AL; Cust AE; Mann GJ; Watts CG; Gyorki DE; Henderson M; Hong AM; Kelly JW; Long GV; Mar VJ; Morton RL; Saw RPM; Scolyer RA; Spillane AJ; Thompson JF; Braithwaite J, 2020, 'Identifying challenges to implementation of clinical practice guidelines for sentinel lymph node biopsy in patients with melanoma in Australia: Protocol paper for a mixed methods study', BMJ Open, 10, http://dx.doi.org/10.1136/bmjopen-2019-032636
2020
Smith AL; Watts CG; Robinson S; Schmid H; Chang CH; Thompson JF; Rapport F; Cust AE, 2020, 'GPs' involvement in diagnosing, treating, and referring patients with suspected or confirmed primary cutaneous melanoma: A qualitative study', BJGP Open, 4, http://dx.doi.org/10.3399/BJGPOPEN20X101028
2020
Guitera P; Collgros H; Madronio CM; Goumas C; Mann GJ; Watts CG; Pereira AR; Armstrong BK; Drummond M; Morton RL; Scolyer RA; Menzies SW; Thompson JF; Cust AE, 2019, 'The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population-based data on diagnosis and management', Australasian Journal of Dermatology, 60, pp. 118 - 125, http://dx.doi.org/10.1111/ajd.12928
2019
Read RL; Madronio CM; Cust AE; Goumas C; Watts CG; Menzies S; Curtin AM; Mann G; Thompson JF; Morton RL, 2018, 'Follow-Up Recommendations after Diagnosis of Primary Cutaneous Melanoma: A Population-Based Study in New South Wales, Australia', Annals of Surgical Oncology, 25, pp. 617 - 625, http://dx.doi.org/10.1245/s10434-017-6319-z
2018
Watts CG; Drummond M; Goumas C; Schmid H; Armstrong BK; Aitken JF; Jenkins MA; Giles GG; Hopper JL; Mann GJ; Cust AE, 2018, 'Sunscreen use and melanoma risk among young Australian adults', JAMA Dermatology, 154, pp. 1001 - 1009, http://dx.doi.org/10.1001/jamadermatol.2018.1774
2018
Watts CG; Wortley S; Norris S; Menzies SW; Guitera P; Askie L; Mann GJ; Morton RL; Cust AE, 2018, 'A National Budget Impact Analysis of a Specialised Surveillance Programme for Individuals at Very High Risk of Melanoma in Australia', Applied Health Economics and Health Policy, 16, pp. 235 - 242, http://dx.doi.org/10.1007/s40258-017-0368-0
2018
Watts CG; Madronio C; Morton RL; Goumas C; Armstrong BK; Curtin A; Menzies SW; Mann GJ; Thompson JF; Cust AE, 2017, 'Clinical features associated with individuals at higher risk of melanoma a population-based study', JAMA Dermatology, 153, pp. 23 - 29, http://dx.doi.org/10.1001/jamadermatol.2016.3327
2017
Watts CG; Cust AE; Menzies SW; Mann GJ; Morton RL, 2017, 'Cost-effectiveness of skin surveillance through a specialized clinic for patients at high risk of Melanoma', Journal of Clinical Oncology, 35, pp. 63 - 71, http://dx.doi.org/10.1200/JCO.2016.68.4308
2017
Watts CG; Madronio CM; Morton RL; Goumas C; Armstrong BK; Curtin A; Menzies SW; Mann GJ; Thompson JF; Cust AE, 2017, 'Diagnosis and clinical management of melanoma patients at higher risk of a new primary melanoma: A population-based study in New South Wales, Australia', Australasian Journal of Dermatology, 58, pp. 278 - 285, http://dx.doi.org/10.1111/ajd.12530
2017
Watts CG, 2017, 'The challenge of skin surveillance: observe or biopsy?', British Journal of Dermatology, 176, pp. 851 - 852, http://dx.doi.org/10.1111/bjd.15450
2017
Madronio CM; Armstrong BK; Watts CG; Goumas C; Morton RL; Curtin A; Menzies SW; Mann GJ; Thompson JF; Cust AE, 2016, 'Doctors’ recognition and management of melanoma patients’ risk: An Australian population-based study', Cancer Epidemiology, 45, pp. 32 - 39, http://dx.doi.org/10.1016/j.canep.2016.09.006
2016
Watts CG; Cust AE; Menzies SW; Coates E; Mann GJ; Morton RL, 2015, 'Specialized surveillance for individuals at high risk for melanoma a cost analysis of a high-risk clinic', JAMA Dermatology, 151, pp. 178 - 186, http://dx.doi.org/10.1001/jamadermatol.2014.1952
2015
Watts CG; Dieng M; Morton RL; Mann GJ; Menzies SW; Cust AE, 2015, 'Clinical practice guidelines for identification, screening and follow-up of individuals at high risk of primary cutaneous melanoma: A systematic review', British Journal of Dermatology, 172, pp. 33 - 47, http://dx.doi.org/10.1111/bjd.13403
2015
Dieng M; Watts CG; Cust AE; Kasparian NA; Morton RL; Mann GJ, 2014, 'Improving subjective perception of personal cancer risk: Systematic review and meta-analysis of educational interventions for people with cancer or at high risk of cancer', Psycho-Oncology, 23, pp. 613 - 625, http://dx.doi.org/10.1002/pon.3476
2014
Dieng M; Watts CG; Kasparian NA; Morton RL; Mann GJ; Cust AE, 2013, 'Improving Subjective Perception of Personal Cancer Risk: Systematic Review and Meta-Analysis of Educational Interventions for People With Cancer or at High Risk of Cancer', PSYCHO-ONCOLOGY, 22, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000325687200090&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
2013
Dieng M; Watts C; Kasparian NA; Morton R; Mann G; Cust A, 2012, 'Improving cancer risk understanding: A systematic review of educational interventions for people with, or at high risk of, cancer', Asia-Pacific Journal of Clinical Oncology, pp. 343 - 343
2012
Watts CG; Andrews RM; Druce JD; Kelly HA, 2003, 'Establishing thresholds for influenza surveillance in Victoria', Australian and New Zealand Journal of Public Health, 27, pp. 409 - 412, http://dx.doi.org/10.1111/j.1467-842X.2003.tb00418.x
2003
Watts C; Kelly H, 2002, 'Fragmentation of influenza surveillance in Australia.', Communicable diseases intelligence, 26, pp. 8 - 13
2002
Watts C, 1992, 'FAP registers in Australia.', Australian family physician, 21, pp. 1037 - 1038
1992
Preprints
Salam RA; Gide TN; Cust AE; Scolyer RA; Long GV; Silva IPD; Ferguson P; Mann GJ; Watts C; Wilmott JS; Smith AL, 2023, Perspectives of health professionals and patients on implementation of a predictive model of response to immunotherapies in advanced melanoma, http://dx.doi.org/10.21203/rs.3.rs-2844230/v1
2023
Miao P; Terris-Prestholt F; Fairley CK; Tucker JD; Wiseman V; Mayaud P; Zhang Y; Rowley J; Gottlieb SL; Korenromp E; Watts C; Ong J, Ignored and Undervalued in Public Health: A Systematic Review of Health State Utility Values Associated with Syphilis Infection, http://dx.doi.org/10.2139/ssrn.4243795
Conference Papers
Nguyen J; Ting S; Paul E; Smith AL; Watts CG; Kelly J; Cust AE; Mar V, 2021, 'Diagnostic tools used for melanoma: A survey of Australian general practitioners and dermatologists', in Australasian Journal of Dermatology, pp. 300 - 309, http://dx.doi.org/10.1111/ajd.13595
2021
Smith AL; Watts C; Robinson S; Mar V; Cust A, 2021, 'Australian dermatologists' knowledge, attitudes and beliefs about the changing role of sentinel lymph node biopsy in melanoma management', in AUSTRALASIAN JOURNAL OF DERMATOLOGY, WILEY, pp. 119 - 119
2021
Smith AL; Watts C; Rapport F; Cust AE, 2020, 'The future of sentinel lymph node biopsy in the management of invasive melanoma in Australia: A mixed-methods study using a determinants of practice implementation science framework', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 96 - 96
2020